Two months after my sister received her one and only flu shot in the late 1990's she was diagnosed with Amyloidosis. She's been fortunate as the protein (growth) has consistently attached to her left eye and can be surgically removed. If it ever moves to any of the vital organs she has six months to live. From her fist diagnosis she has always believed it was the flu shot. No, she never got jabbed with their "spike proteins" despite continuing to be a nurse at a hospital.
Interesting. I found some really insightful articles from 2016/2017 about Moderna’s venture into the same sphere. I’ll link a few, but here’s a quote.
“In order to protect mRNA molecules from the body’s natural defenses, drug developers must wrap them in a protective casing. For Moderna, that meant putting its Crigler-Najjar therapy in nanoparticles made of lipids. And for its chemists, those nanoparticles created a daunting challenge: Dose too little, and you don’t get enough enzyme to affect the disease; dose too much, and the drug is too toxic for patients.”
Two months after my sister received her one and only flu shot in the late 1990's she was diagnosed with Amyloidosis. She's been fortunate as the protein (growth) has consistently attached to her left eye and can be surgically removed. If it ever moves to any of the vital organs she has six months to live. From her fist diagnosis she has always believed it was the flu shot. No, she never got jabbed with their "spike proteins" despite continuing to be a nurse at a hospital.
Doesn't say how long the test animals lived after they were physically assaulted with this crap. Call me silly, but I think that's an important point.
OK, you're silly. But you're also right: it's an important point.
...the life span of a laboratory animal is finite....
Interesting. I found some really insightful articles from 2016/2017 about Moderna’s venture into the same sphere. I’ll link a few, but here’s a quote.
“In order to protect mRNA molecules from the body’s natural defenses, drug developers must wrap them in a protective casing. For Moderna, that meant putting its Crigler-Najjar therapy in nanoparticles made of lipids. And for its chemists, those nanoparticles created a daunting challenge: Dose too little, and you don’t get enough enzyme to affect the disease; dose too much, and the drug is too toxic for patients.”
That’s from this article
https://www.statnews.com/2017/01/10/moderna-trouble-mrna/#
But read this one first because it gives many insights into the company and came out the year prior.
https://www.statnews.com/2016/09/13/moderna-therapeutics-biotech-mrna/
https://www.judicialwatch.org/nanoparticles-materials-outside-injection-site/
Secondary link from first link for you.
Good doggie!
...wonderful information...
...I will Unleash it later today...